Challenges and lessons learned from Covid-19 trials – should we be doing clinical trials differently? release_mvjqk2m5mfhvlh7zxv2xzwtalu

by Perrine Janiaud, Lars G. Hemkens, John Ioannidis

Cited By

References to this release by other works.
Fuzzy reference matching is a work in progress!
Read more about quality, completeness, and caveats in the fatcat guide.
Showing 1 - 2 of 2 references (in 70ms)

via fatcat-pubmed
Characteristics and Research Waste Among Randomized Clinical Trials in Gastric Cancer
Jun Lu, Bin-bin Xu, Li-li Shen, Dong Wu, Zhen Xue, Hua-Long Zheng, Jian-Wei Xie, Jia-Bin Wang (+ more)
2021   JAMA Network Open
doi:10.1001/jamanetworkopen.2021.24760  pmcid:PMC8449283  pmid:34533573 
web.archive.org [PDF]

via crossref
Randomized trials on non-pharmaceutical interventions for COVID-19 as of August 2021: a meta-epidemiological analysis [post]
Julian Hirt, Perrine Janiaud, Lars G. Hemkens
2021    unpublished
doi:10.1101/2021.08.20.21261687 
web.archive.org [PDF]